NFAM1通过脂筏限制性DAPP1-PLCG2模块驱动胶质瘤M2样GAM极化
该研究利用转录组分析、人胶质瘤标本、GAM模型和原位胶质瘤模型,明确NFAM1在单核细胞来源的M2样GAM中富集,并与高级别、IDH野生型及不良生存相关。机制上NFAM1通过ITAM-SH2依赖的脂筏内DAPP1-PLCG2-Ca²⁺-NFAT1信号模块促进GAM迁移和M2样极化,增强GSC间质可塑性、血管生成和胶质瘤进展;干预NFAM1可抑制肿瘤生长并延长生存。
要点
- NFAM1富集于单核细胞来源的M2样GAM,与高级别、IDH野生型及不良生存相关
- NFAM1经脂筏内DAPP1-PLCG2-Ca²⁺-NFAT1模块驱动GAM M2样极化
- 靶向NFAM1可抑制肿瘤生长并延长生存,依赖外周巨噬细胞
核心结论
- NFAM1在单核细胞来源的GAM中空间组织脂筏限制性DAPP1-PLCG2-Ca²⁺-NFAT1信号,是胶质瘤可治疗靶点。
研究设计与样本
- 研究采用bulk和单细胞转录组分析、人胶质瘤标本、GAM模型及原位胶质瘤模型。
- 机制研究使用脂筏分离、共免疫沉淀、邻近连接、结构域突变体 rescue、IP3和Ca²⁺检测及NFAT1核转位实验。
- 治疗相关性评估使用药理学、巨噬细胞清除/重建及诱导型遗传模型。
主要发现
- NFAM1富集于单核细胞来源的M2样GAM,与更高级别胶质瘤、IDH野生型状态和不良生存相关。
- NFAM1促进GAM迁移和M2样极化,增强胶质瘤干细胞间质可塑性、血管生成和胶质瘤进展。
- 磷酸化NFAM1通过ITAM-SH2依赖相互作用在脂筏内招募DAPP1和PLCG2,形成空间协调且功能有序的信号模块。
- DAPP1作用于PLCG2上游,促进IP3产生、Ca²⁺信号和NFAT1核转位。
- Madecassoside以ITAM依赖方式靶向NFAM1,破坏信号模块,抑制肿瘤支持性GAM表型,减少原位肿瘤生长并延长生存。
关键数值与推荐
- 外周巨噬细胞清除或NFAM1缺陷骨髓来源巨噬细胞重建后,Madecassoside抗肿瘤活性明显减弱。
- 肿瘤建立后对重建BMDM来源GAM诱导性敲低NFAM1,可减少肿瘤负荷并延长生存。
临床怎么用
- NFAM1可作为胶质瘤GAM靶向干预的候选分子,但当前证据限于临床前模型。
- Madecassoside的活性依赖外周巨噬细胞和NFAM1,提示需结合巨噬细胞状态评估疗效。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glioma-associated macrophages (GAMs) promote glioma progression, but the membrane-proximal mechanisms sustaining their tumor-supportive states remain poorly defined. METHODS: Bulk and single-cell transcriptomic analyses, human glioma specimens, GAM models, and orthotopic glioma models were used to define the expression and function of NFAM1. Lipid-raft fractionation, co-immunoprecipitation, proximity ligation, domain-mutant rescue, IP3 and Ca²⁺ measurements, and NFAT1 nuclear translocation assays delineated its signaling mechanism. Pharmacological, macrophage-depletion/reconstitution, and inducible genetic models evaluated its therapeutic relevance. RESULTS: NFAM1 was enriched in monocyte-derived, M2-like GAMs and associated with higher glioma grade, IDH-wild-type status, and poor survival. NFAM1 promoted GAM migration and M2-like polarization, thereby enhancing mesenchymal plasticity of glioma stem cells (GSCs), angiogenesis, and glioma progression. Mechanistically, phosphorylated NFAM1 recruited DAPP1 and PLCG2 through ITAM-SH2-dependent interactions within lipid rafts, organizing a spatially coordinated and functionally ordered signaling module. DAPP1 acted upstream of PLCG2 to promote IP3 production, Ca²⁺ signaling, and NFAT1 nuclear translocation. Madecassoside showed ITAM-dependent cellular target engagement with NFAM1, disrupted this signaling module, suppressed tumor-supportive GAM phenotypes, reduced orthotopic tumor growth, and prolonged survival. Its antitumor activity was markedly diminished after peripheral macrophage depletion or reconstitution with NFAM1-deficient bone marrow-derived macrophages. Moreover, inducible NFAM1 knockdown in reconstituted BMDM-derived GAMs after tumor establishment reduced tumor burden and extended survival. CONCLUSIONS: NFAM1 spatially organizes lipid-raft-restricted DAPP1-PLCG2-Ca²⁺-NFAT1 signaling in monocyte-derived GAMs and represents a therapeutically targetable vulnerability in glioma. Glioblastoma is an aggressive brain cancer shaped by immune cells around the tumor. This study asked how NFAM1, a molecule found in tumor-associated immune cells, contributes to disease progression. We found that NFAM1 promotes the movement and tumor-supporting behavior of macrophages, which in turn make cancer stem-like cells more aggressive and encourage blood-vessel formation. Importantly, switching off NFAM1 in these macrophages after tumors had already formed reduced tumor growth and prolonged survival in mice. The natural compound madecassoside also targeted NFAM1 and slowed tumor growth. These findings identify NFAM1 as a potential treatment target for glioblastoma.
引用
- Zhang Y, Chen R, Song Y, et al. NFAM1 organizes a lipid raft-restricted DAPP1-PLCG2 module to drive M2-like GAM polarization via Ca²⁺-NFAT1 signaling in glioma. Neuro Oncol. 2026. PMID: 42820763. doi:10.1093/neuonc/noag240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。